Intensity Therapeutics Statistics
Total Valuation
INTS has a market cap or net worth of $29.01 million. The enterprise value is $27.15 million.
Important Dates
The last earnings date was Thursday, March 13, 2025, after market close.
Earnings Date | Mar 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
INTS has 15.18 million shares outstanding. The number of shares has increased by 61.40% in one year.
Current Share Class | 15.18M |
Shares Outstanding | 15.18M |
Shares Change (YoY) | +61.40% |
Shares Change (QoQ) | +4.32% |
Owned by Insiders (%) | 22.83% |
Owned by Institutions (%) | 10.51% |
Float | 6.86M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 10.11 |
P/TBV Ratio | 10.14 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.05.
Current Ratio | 1.92 |
Quick Ratio | 1.48 |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -202.34% and return on invested capital (ROIC) is -126.60%.
Return on Equity (ROE) | -202.34% |
Return on Assets (ROA) | -93.90% |
Return on Invested Capital (ROIC) | -126.60% |
Return on Capital Employed (ROCE) | -547.72% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.32M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.39% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -61.39% |
50-Day Moving Average | 2.25 |
200-Day Moving Average | 3.33 |
Relative Strength Index (RSI) | 39.38 |
Average Volume (20 Days) | 38,224 |
Short Selling Information
The latest short interest is 51,912, so 0.34% of the outstanding shares have been sold short.
Short Interest | 51,912 |
Short Previous Month | 49,914 |
Short % of Shares Out | 0.34% |
Short % of Float | 0.76% |
Short Ratio (days to cover) | 1.98 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -16.59M |
Pretax Income | -15.07M |
Net Income | -16.27M |
EBITDA | n/a |
EBIT | -16.59M |
Earnings Per Share (EPS) | -$1.17 |
Full Income Statement Balance Sheet
The company has $2.59 million in cash and $138,000 in debt, giving a net cash position of $2.45 million or $0.16 per share.
Cash & Cash Equivalents | 2.59M |
Total Debt | 138,000 |
Net Cash | 2.45M |
Net Cash Per Share | $0.16 |
Equity (Book Value) | 2.92M |
Book Value Per Share | 0.19 |
Working Capital | 1.61M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -15.22M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |